ATE393216T1 - Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln - Google Patents

Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln

Info

Publication number
ATE393216T1
ATE393216T1 AT97925652T AT97925652T ATE393216T1 AT E393216 T1 ATE393216 T1 AT E393216T1 AT 97925652 T AT97925652 T AT 97925652T AT 97925652 T AT97925652 T AT 97925652T AT E393216 T1 ATE393216 T1 AT E393216T1
Authority
AT
Austria
Prior art keywords
catalysts
formulations
cross
organic solvents
linked protein
Prior art date
Application number
AT97925652T
Other languages
English (en)
Inventor
Nazer Khalaf
Original Assignee
Altus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altus Pharmaceuticals Inc filed Critical Altus Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE393216T1 publication Critical patent/ATE393216T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97925652T 1996-05-24 1997-05-20 Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln ATE393216T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/652,964 US5932212A (en) 1996-05-24 1996-05-24 Crosslinked protein crystal formulations and their use as catalysts in organic solvents

Publications (1)

Publication Number Publication Date
ATE393216T1 true ATE393216T1 (de) 2008-05-15

Family

ID=24618946

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97925652T ATE393216T1 (de) 1996-05-24 1997-05-20 Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln

Country Status (13)

Country Link
US (2) US5932212A (de)
EP (1) EP0906417B1 (de)
JP (2) JP4279351B2 (de)
KR (1) KR20000015993A (de)
AR (1) AR007211A1 (de)
AT (1) ATE393216T1 (de)
AU (1) AU3072897A (de)
DE (1) DE69738648T2 (de)
DK (1) DK0906417T3 (de)
ID (1) ID17817A (de)
IN (1) IN191060B (de)
WO (1) WO1997044445A1 (de)
ZA (1) ZA974325B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009750A1 (en) * 1990-11-29 1992-06-11 Willis Richard R Floating contaminant containment systems
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
EP0988112B1 (de) * 1997-06-20 2010-04-14 New York University Elektrosprühen von lösungen zur massenherstellung von chips und molekülbibliotheken
US6833275B1 (en) * 1997-07-22 2004-12-21 Roche Diagnostics Gmbh Gold conjugates containing detergent
ATE397013T1 (de) 1997-09-05 2008-06-15 Altus Pharmaceuticals Inc Kohlenhydrat-vernetzte glykoproteinkristalle
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
ZA988461B (en) * 1997-09-18 1999-03-30 Idec Pharma Corp Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
JP4965022B2 (ja) * 1998-04-27 2012-07-04 アルタス ファーマシューティカルズ インコーポレイテッド 安定化されたタンパク質結晶、それを含む処方物、およびそれを作製する方法
US6979561B1 (en) 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
JP4532740B2 (ja) * 1998-10-09 2010-08-25 アルタス・バイオロジツクス・インコーポレイテツド エナンチオマー混合物の分割用非均一系
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
AU6574400A (en) * 1999-08-18 2001-03-13 Hydrios Biotechnology Oy Process for the preparation and simultaneous separation of enzyme-catalysed products
US7300775B2 (en) 1999-12-29 2007-11-27 Verenium Corporation Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents
US7521216B2 (en) 1999-12-29 2009-04-21 Verenium Corporation Nitrilases and methods for making and using them
US7608445B1 (en) 1999-12-29 2009-10-27 Verenium Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US20040014195A1 (en) * 1999-12-29 2004-01-22 Diversa Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
EP1292823A1 (de) * 2000-05-23 2003-03-19 Radiometer Medical A/S "sensormembran, verfahren zu ihrer herstellung, sensor und geschichtete membranstruktur f r einen solchen sensor"
KR20100031769A (ko) 2000-12-28 2010-03-24 알투스 파마슈티컬스 인코포레이티드 전항체 및 이의 단편의 결정과 이의 제조 및 사용 방법
JP2005500304A (ja) 2001-06-21 2005-01-06 アルタス バイオロジックス インコーポレイテッド 球状タンパク質粒子およびそれらの作製方法および使用方法
AU2003251523A1 (en) 2002-06-13 2003-12-31 Diversa Corporation Processes for making (r)-ethyl 4-cyano-3-hydroxybutyric acid
US9035123B2 (en) 2002-10-01 2015-05-19 The Procter & Gamble Company Absorbent article having a lotioned topsheet
JP2006523609A (ja) * 2002-12-31 2006-10-19 アルタス ファーマシューティカルズ インコーポレイテッド タンパク質結晶およびイオン性ポリマーの複合体
MXPA05007181A (es) * 2002-12-31 2006-04-07 Altus Pharmaceuticals Inc Cristales de la hormona de crecimiento humano y metodos para prepararlos.
EP1699921B1 (de) * 2004-01-01 2009-11-04 Council of Scientific and Industrial Research;an Indian Reg. body incorporated under Reg. of Societies Act (Act XXI of 1860) Methode zur herstellung von quervernetzten protein kristallen
ATE474592T1 (de) * 2004-10-14 2010-08-15 Altus Pharmaceuticals Inc Zusammensetzungen enthaltend lipase, protease und amylase zur behandlung von pankreasinsuffizienz
WO2007050100A2 (en) * 2004-11-24 2007-05-03 Industrial Science & Technology Network, Inc. Immobilized enzymes and processes for preparing and using same
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
US20090023629A1 (en) * 2005-12-23 2009-01-22 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
US20100047413A1 (en) * 2006-09-15 2010-02-25 Cabalka Tourtellotte Leanne M Method of using amphiphilic multiblock copolymers in food
DK2115153T3 (da) 2007-03-01 2013-09-08 Bp Corp North America Inc Nitrilaser, nucleinsyrer som koder for dem og fremgangsmåder til at fremstille og anvende disse
IL183084A0 (en) * 2007-05-09 2007-09-20 Trans Biodisel Ltd Modified-immobilized enzymes of high tolerance to hydrophilic substrates in organic media
CN101717766B (zh) * 2009-12-01 2012-07-18 暨南大学 蛋白质酶的微水介质固定化方法
WO2012003336A2 (en) 2010-06-30 2012-01-05 Codexis, Inc. Chemically modified carbonic anhydrases useful in carbon capture systems
JP5740754B2 (ja) * 2010-08-26 2015-07-01 アイシン精機株式会社 酵素結晶固定化電極及び酵素結晶固定化電極の製造方法、並びに酵素結晶固定化電極を備えるバイオ電池及びバイオセンサー

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267234A (en) * 1978-03-17 1981-05-12 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US4369226A (en) * 1979-03-19 1983-01-18 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US5152903A (en) * 1988-12-19 1992-10-06 American Cyanamid Company Cross-linked cationic polymeric microparticles
IE912767A1 (en) * 1990-08-03 1992-02-12 Vertex Pharma Use of crosslinked crystals as a novel form of enzyme¹immobilization
GB9309243D0 (en) * 1993-05-05 1993-06-16 Allied Colloids Ltd Enzyme dispersions,their production and compositions containing them
WO1994028118A1 (en) * 1993-05-20 1994-12-08 Loders Croklaan B.V. Immobilized lipases
ES2148479T3 (es) * 1993-12-03 2000-10-16 Buckman Labor Inc Estabilizacion de enzimas por medio de secuencias de copolimeros.
DE4344211A1 (de) * 1993-12-23 1995-06-29 Basf Ag Verfahren zur Erhöhung der Aktivität von hydrolytischen Enzymen

Also Published As

Publication number Publication date
US5932212A (en) 1999-08-03
AR007211A1 (es) 1999-10-13
WO1997044445A1 (en) 1997-11-27
DE69738648T2 (de) 2009-05-28
ID17817A (id) 1998-01-29
AU3072897A (en) 1997-12-09
DE69738648D1 (de) 2008-06-05
ZA974325B (en) 1997-12-18
JP2008061652A (ja) 2008-03-21
JP2000514282A (ja) 2000-10-31
DK0906417T3 (da) 2008-07-21
EP0906417A1 (de) 1999-04-07
EP0906417B1 (de) 2008-04-23
US6042824A (en) 2000-03-28
IN191060B (de) 2003-09-13
JP4279351B2 (ja) 2009-06-17
KR20000015993A (ko) 2000-03-25

Similar Documents

Publication Publication Date Title
ATE393216T1 (de) Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln
DE59712887D1 (de) Substituierte phenylketoenole und ihre verwendung als schädlingsbekämpfungsmittel
DE69511860D1 (de) Modifizierung von clostridium-toxinen und ihre anwendung als transport proteine
DE59812907D1 (de) Substituierte Isochinolin-3-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DE59710422D1 (de) Acylmercapto-triazolyl-derivate und ihre verwendung als mikrobizide
DE59710580D1 (de) Thiocyano-triazolyl-derivate und ihre verwendung als mikrobizide
DE69720389D1 (de) Zementzusammensetzungen und ihre Verwendung
DE69836346D1 (de) Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer
DE69702970T2 (de) N-arylsulfilimin-verbindungen und ihre anwendung als katalysatoren in der herstellung von n-aryl-arylsulfonamid-verbindungen
DE59706602D1 (de) 3-Hydroxy-Pyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
ATE227266T1 (de) Aromatische c16-c20-substituierte tetrahydro- prostaglandine und ihre verwendung als prostaglandin f agonisten
DE59804276D1 (de) Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
DE59708905D1 (de) Injektionsformulierungen von avermectinen und milbemycinen
DE69825202D1 (de) Kautschukzusammensetzung und ihre Verwendung in Reifen
ATE227278T1 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
DE59701610D1 (de) Verwendung von sarkosinaten als asphalten-dispergatoren
DE69708629T2 (de) Alkyloxyamin-substituierte fluorenonderivate und ihre verwendung als proteinkinase-c-inhibitoren
ATE233569T1 (de) Verwendung von proteine als mittel gegen autoimmunekrankheiten
DE69728938D1 (de) Peptidantagonisten der zellulären mitogenese und motogenese und deren therapeutische verwendung
DE59711049D1 (de) Kosmetisches Hautbräunungs- und Lichtschutzmittel
NO990806L (no) Biologisk nedbrytning av eksplosiver
DE69706128T2 (de) Estermischung und ihre verwendung
DE69717631D1 (de) Bestimmung von teilchenförmigen verunreinigungen
DE59809194D1 (de) 8-Ocimenylester und ihre Verwendung als Riech- und Aromastoffe
DE69719750T2 (de) Kosmetische haarwaschmittel und ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties